1997
DOI: 10.1023/a:1018855928753
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: beta2-Microglobulin (beta2-MG) plays a key role in influencing the immune response to viral infections as it is an integrating part of the main histocompatibility system (HLA). We attempted to evaluate the changes in class I HLA antigens by comparing the serum beta2-MG behavior in a group of patients affected by chronic hepatitis C with that observed in a group of healthy controls. Our study revealed that the patients presented higher serum beta2-MG levels than healthy controls (P = 0.0003). beta2-MG levels we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
7
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…A number of studies have suggested that β-2m may be a useful marker in the development of hepatitis (Rashid et al 1981;Nagafuchi and Scheuer 1986;Yegane et al 2004). The measurement of β-2m levels in a number of hepatic diseases revealed that significantly elevated levels are found in the serum of patients with alcoholic and biliary cirrhosis, chronic hepatitis C, and metastatic liver cancer (Rashid et al 1981;Malaguarnera et al 1997). …”
Section: Discussionmentioning
confidence: 99%
“…A number of studies have suggested that β-2m may be a useful marker in the development of hepatitis (Rashid et al 1981;Nagafuchi and Scheuer 1986;Yegane et al 2004). The measurement of β-2m levels in a number of hepatic diseases revealed that significantly elevated levels are found in the serum of patients with alcoholic and biliary cirrhosis, chronic hepatitis C, and metastatic liver cancer (Rashid et al 1981;Malaguarnera et al 1997). …”
Section: Discussionmentioning
confidence: 99%
“…2 The circulating concentration of β2m in DRA patients increases up to ∼60 times above the normal level of 0.1 μM, but elevated β2m concentrations alone are not sufficient to trigger fibrillogenesis. 3,4 β2m amyloid formation must therefore result from other factors related to hemodialysis, but the exact mechanism in vivo is not known. In vitro , β2m oligomerization and fibril formation can be generated several ways, including by incubation of the protein under acidic conditions, 5 by truncation of the first six N-terminal amino acids, 6 by mixing the protein with collagen at pH 6.4, 7 by sonication of the protein with sodium dodecyl sulfate at pH 7.0, 8 and by incubation of the protein under physiological conditions in the presence of stoichiometric amounts of Cu(II).…”
mentioning
confidence: 99%
“…Upon renal failure, serum levels of β2m increase up to ~60 times above their normal levels of about 0.1 µM, and the protein aggregates into insoluble amyloid deposits (3,4). An elevated level of β2m, however, is not unique to renal failure patients and is not sufficient to trigger fibrillogenesis (5,6). β2m amyloid formation must therefore result from factors particular to hemodialysis.…”
mentioning
confidence: 99%